<DOC>
	<DOC>NCT00490945</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.</brief_summary>
	<brief_title>Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Disorders, Circadian Rhythm</mesh_term>
	<criteria>No medical, psychiatric, or sleep disorders Ability to provide written informed consent Lifetime history of night shift work Evidence of any sleep disorder Psychiatric or neurological disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>